Candel Therapeutics (CADL) Leases (2022 - 2025)
Candel Therapeutics recorded quarterly Leases of $1.7 million in Q4 2025, down 5.09% quarter-over-quarter from $1.8 million in Q3 2025, and up 206.46% year-over-year from $542000.0 in Q4 2024.
Candel Therapeutics' Leases history runs 4 years deep, the most recent figure standing at $1.7 million for Q4 2025.
- In Q4 2025, Leases rose 206.46% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (up 206.46% YoY), while the FY2025 annual figure was $1.7 million, up 206.46% from the prior year.
- Leases came in at $1.7 million for Q4 2025 at Candel Therapeutics, down from $1.8 million in the prior quarter.
- In the past five years, Leases ranged from a high of $1.8 million in Q3 2025 to a low of $391000.0 in Q2 2025.
- A 4-year average of $940000.0 and a median of $909500.0 in 2023 frame the typical range for Leases.
- On a YoY basis, Leases climbed as much as 206.46% in 2025 and fell as far as 42.84% in 2025.
- Candel Therapeutics' Leases stood at $1.1 million in 2022, then decreased by 22.73% to $816000.0 in 2023, then tumbled by 33.58% to $542000.0 in 2024, then jumped by 206.46% to $1.7 million in 2025.
- According to Business Quant data, Leases over the past three periods registered $1.7 million, $1.8 million, and $391000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Candel Therapeutics | 449.62 Mn | 449.62 Mn | - | 1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 391,000.00 |
| Mar 31, 2025 | 468,000.00 |
| Dec 31, 2024 | 542,000.00 |
| Sep 30, 2024 | 614,000.00 |
| Jun 30, 2024 | 684,000.00 |
| Mar 31, 2024 | 751,000.00 |
| Dec 31, 2023 | 816,000.00 |
| Sep 30, 2023 | 879,000.00 |
| Jun 30, 2023 | 940,000.00 |
| Mar 31, 2023 | 999,000.00 |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 1.22 Mn |